Medtronic receives fda approval for inceptiv™ closed-loop spinal cord stimulator

Closed-loop sensing capability instantly and automatically adjusts therapy while treating chronic pain dublin , april 26, 2024 /prnewswire/ -- medtronic plc (nyse:mdt), a global leader in healthcare technology, today announced that the u.s. food and drug administration (fda) has approved the inceptiv™ closed-loop rechargeable spinal cord stimulator (scs) for the treatment of chronic pain. inceptiv is the first medtronic scs device to offer a closed-loop feature that senses biological signals along the spinal cord and automatically adjusts stimulation in real time, keeping therapy in harmony with the motions of daily life.
MDT Ratings Summary
MDT Quant Ranking